which method has been used in the best trials of treatments designed to reduce these risks, since such studies are the source of information for decisions to treat.
Netea and colleagues rightly pick up on this in their discussion: 'in what (arm) position has the blood pressure been measured in the large epidemiological and outcome studies?' If the studies which provide the information on the BP levels at which treatment confers benefit have used the 'arm resting on the desktop' method, shouldn't that be the standard, regardless of whether it is close to the 'true' BP or not? After all, we are aiming to lower risk, not to treat the BP per se. And by and large, Netea et al tell us, it's bad news. The position of the arm in most of the major studies is not known. Surely such information (along with cuff size and the other sources of systematic variation) should be one focus of systematic reviews of such studies-not only to synthesise outcome data but to find out and characterise the circumstances in which the measurements were made.
Standardising indirect BP measurement to the heart level may make sense if this reduces variation in everyday practice compared with a 'desktop level' approach. However this is only true if that measurement also provides a better absolute level on which to base treatment choice. The current paper adds to the genre of methodological studies, but these only tell part of the story. For everyday clinical decision-making there is a crucial part of the jigsaw missing. Systematic overviews of data from the older studies or new original studies, such as the one reported by Tsuji et al, 2 are needed which compare different methods of BP measurement in order to find which best predicts future morbidity and mortality from the complications of raised BP. The setting of standards and the minimisation of variation can then be focused on the method for which there is empirical evidence that it provides the best basis for decisions to treat.
